Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Clal Bio Surges Most in a Month as Unit Gets FDA Approval

Clal Biotechnology Industries Ltd. advanced the most in a month after a unit got the U.S. Food and Drug Administration orphan drug status for its DiaPep277 treatment for juvenile diabetes.

The shares of the investment company rose 3.9 percent, the most since April 22, to 12.93 shekels at the 4:30 p.m. close in Tel Aviv.

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.